METTL3/miR-196a轴预测非小细胞肺癌的预后不佳

Zhen Yang1,2, Jie Hao3, Minghan Qiu2,4

  • 1Department of Clinical Laboratory, Tianjin Union Medical Center of Nankai University, Tianjin 300121, China.

Journal of Cancer
|February 19, 2024
PubMed
概括

上调METTL3通过METTL3-miR-196a-GAS7轴促进非小细胞肺癌 (NSCLC) 的进展. 这一途径影响瘤生长,可能成为NSCLC的新型诊断和治疗点.